Kymera Therapeutics, Inc. rStock RKYMR
RKYMR
?
$
%
Change 24h
Market Cap
$ ?
Volume 24h
$ ?
RKYMR
$
Description
Clinical-stage biopharmaceutical company developing novel small molecule protein degraders for oncology and immunology.